iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
2.410
+0.040 (1.69%)
At close: Jan 21, 2025, 4:00 PM
2.330
-0.080 (-3.32%)
Pre-market: Jan 22, 2025, 6:15 AM EST
iSpecimen Employees
iSpecimen had 53 employees as of December 31, 2023. The number of employees decreased by 22 or -29.33% compared to the previous year.
Employees
53
Change (1Y)
-22
Growth (1Y)
-29.33%
Revenue / Employee
$196,051
Profits / Employee
-$179,697
Market Cap
2.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 53 | -22 | -29.33% |
| Dec 31, 2022 | 75 | 16 | 27.12% |
| Dec 31, 2021 | 59 | 18 | 43.90% |
| Dec 31, 2020 | 41 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ISPC News
- 5 days ago - iSpecimen Secures Suppliers for COVID-style hMPV Outbreak - Newsfile Corp
- 4 weeks ago - iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens - Newsfile Corp
- 5 weeks ago - iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers - Newsfile Corp
- 5 weeks ago - iSpecimen Appoints Robert Lim as CEO and Director - Newsfile Corp
- 2 months ago - iSpecimen Named Top Competitor in $4.4 Billion USD Market - Newsfile Corp
- 2 months ago - iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - GlobeNewsWire
- 2 months ago - iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire